Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Roles of Electrolytes: Sodium and Potassium01:24

Roles of Electrolytes: Sodium and Potassium

236
Sodium plays a crucial role in maintaining fluid and electrolyte balance and overall bodily homeostasis. Sodium balance is primarily regulated by kidney function, which adjusts sodium elimination to match dietary intake and maintain proper electrolyte levels. Sodium is the most abundant cation in the extracellular fluid (ECF) and is found in salts such as sodium chloride (NaCl) and sodium bicarbonate (NaHCO3). Although cellular plasma membranes are relatively impermeable to sodium, its role in...
236
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

10.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

3.4K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes Mellitus.

Kidney international reports·2026
Same author

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.

The New England journal of medicine·2026
Same author

Acute Kidney Injury in a Patient With Metastatic Leiomyosarcoma: A Quiz.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198.

Lancet (London, England)·2026
Same author

Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence.

Kidney international reports·2026
Same author

Serological pseudoprogression of multiple myeloma after treatment with teclistamab.

Leukemia & lymphoma·2025

Related Experiment Video

Updated: May 25, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

2.2K

Electrolytes Abnormalities in Cancer Patients.

Arash Rashidi1, Nada Youssef2, Biruh Workeneh2

  • 1Division of Nephrology and Hypertension, Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA, arash.rashidi@uhhospitals.org.

American Journal of Nephrology
|February 25, 2025
PubMed
Summary

Electrolyte imbalances are common in cancer patients, affecting treatment and quality of life. This review details cancer-specific electrolyte disturbances and their management.

Keywords:
CalciumMagnesiumPhosphorusPotassiumSodium

More Related Videos

Electrochemotherapy of Tumours
03:57

Electrochemotherapy of Tumours

Published on: December 15, 2008

24.4K
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.1K

Related Experiment Videos

Last Updated: May 25, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

2.2K
Electrochemotherapy of Tumours
03:57

Electrochemotherapy of Tumours

Published on: December 15, 2008

24.4K
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.1K

Area of Science:

  • Oncology
  • Nephrology
  • Internal Medicine

Background:

  • Electrolyte disorders are prevalent in cancer patients, impacting treatment outcomes and quality of life.
  • These disorders present unique challenges in cancer care compared to the general population due to specific etiologies and complexities.

Purpose of the Study:

  • To review key electrolyte imbalances in cancer patients, including sodium, potassium, magnesium, calcium, and phosphorus disorders.
  • To highlight the clinical presentations and management strategies for cancer-specific electrolyte disturbances.
  • To emphasize the importance of regular electrolyte monitoring and prompt intervention in oncology.

Main Methods:

  • Literature review of electrolyte disturbances in cancer patients.
  • Analysis of electrolyte derangements associated with various cancer therapies, including surgical, radiologic, cellular, checkpoint inhibitor, and cytotoxic chemotherapy treatments.

Main Results:

  • Cancer therapies can lead to specific patterns of electrolyte imbalances.
  • Common electrolyte disorders discussed include hyponatremia, hypernatremia, hypokalemia, hyperkalemia, and abnormalities in magnesium, calcium, and phosphorus.

Conclusions:

  • Understanding the pathogenesis of cancer-related electrolyte disorders is crucial for effective management.
  • Timely intervention and regular monitoring are essential for optimizing care and improving outcomes for cancer patients with electrolyte disturbances.